Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs)

Multiple nucleic acid amplification tests (NATs) are available for the detection of SARS-CoV-2 in clinical specimens, including Laboratory Developed Tests (LDT), commercial high-throughput assays and point-of-care tests. Some assays were just recently released and there is limited data on their clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohmer, Niko, Rabenau, Holger F., Hoehl, Sebastian, Kortenbusch, Marhild, Ciesek, Sandra, Berger, Annemarie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885623/
https://www.ncbi.nlm.nih.gov/pubmed/33607117
http://dx.doi.org/10.1016/j.jviromet.2021.114102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885623/
https://www.ncbi.nlm.nih.gov/pubmed/33607117
http://dx.doi.org/10.1016/j.jviromet.2021.114102

Ejemplares similares